Ion Transport Modulators as Antimycobacterial Agents

There is an urgent need for better and safer therapeutic interventions for tuberculosis (TB). We assessed the effects of FDA-approved ion transport modulators, namely, ambroxol HCl, amiloride HCl, diazoxide, digoxin, furosemide, hydrochlorothiazide (HCTZ), metformin, omeprazole, pantoprazole, phenyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitini-Nkhoma, Steven C., Fernando, Narmada, Ishaka, G. K. D., Handunnetti, Shiroma M., Pathirana, Sisira L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700046/
https://www.ncbi.nlm.nih.gov/pubmed/33294223
http://dx.doi.org/10.1155/2020/3767915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700046/
https://www.ncbi.nlm.nih.gov/pubmed/33294223
http://dx.doi.org/10.1155/2020/3767915

Ejemplares similares